NCT05486351View on ClinicalTrials.gov

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke

UnknownOBSERVATIONAL
Enrollment

318

Participants

Timeline

Start Date

March 5, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Cardioembolic StrokeAnticoagulant TherapyStroke RecurrenceHaemorrhagic Transformation Stroke
Interventions
OTHER

Observation

Patients are observed for stroke or systemic embolism and haemorrhagic transformation

Trial Locations (3)

28040

RECRUITING

Jimenez Diaz Fundation University Hospital, Madrid

28046

RECRUITING

La Paz University Hospital, Madrid

75018

ACTIVE_NOT_RECRUITING

Bichat Claude Bernard Hospital, Paris

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Hospital Universitario La Paz

OTHER

collaborator

Daiichi Sankyo

INDUSTRY

collaborator

Fundación Freno al ICTUS

UNKNOWN

lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT05486351 - Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke | Biotech Hunter | Biotech Hunter